## 2 Results
### Optimization of HS-SPME-GC \(\times\) GC-TOFMS Methodology
\begin{table}
\begin{tabular}{l c c c c c c c c c c c c c} \hline \hline \multirow{2}{*}{**Compounds**} & \multirow{2}{*}{**\({}^{1}\)D\({}_{\text{L}}\) (incl)\({}^{\ast}\)**} & \multirow{2}{*}{**\({}^{2}\)D\({}_{\text{L}}\) (incl)\({}^{\ast}\)**} & \multirow{2}{*}{**LBL (incl)\({}^{\ast}\)**} & \multirow{2}{*}{**LBL (incl)\({}^{\ast}\)**} & \multicolumn{2}{c}{**Valerite 2021**} & \multicolumn{2}{c}{**Valerite 2022**} & \multicolumn{2}{c}{**Time**} & \multicolumn{1}{c}{**CS**} & \multicolumn{1}{c}{**TB**} & \multicolumn{1}{c}{**Sy**} & \multicolumn{1}{c}{**Cat**} & \multicolumn{1}{c}{**Time**} & \multicolumn{1}{c}{**CS**} & \multicolumn{1}{c}{**TB**} & \multicolumn{1}{c}{**Sy**} & \multicolumn{1}{c}{**Cat**} \\ \cline{6-13} \cline{8-13} \cline{12-13}  & & & & & & & & & & & & & & & & & & & \\ \hline \multicolumn{13}{c}{**Monoteropically Compounds**} & & & & & & & & & & & & & & & & & & \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 19.322 & 3.00 & 966 & 992 & nd & nd & ed & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 19.33 & 3.34 & 1024 & 1031 & 2.31 \(\pm\) 0.42 & 3.60 \(\pm\) 0.24 & 2.16 \(\pm\) 0.28 & 1.60 \(\pm\) 0.33 & 4.19 \(\pm\) 0.15 & 1.06 \(\pm\) 0.43 & 2.74 \(\pm\) 0.45 & 3.58 \(\pm\) 1.51 & 12.7 \(\pm\) 0.12 & 1.75 \(\pm\) 0.64 \\ \multicolumn{13}{c}{**S**-Mycone**} & 12.50 & 3.12 & 1027 & 1035 & 1.50 \(\pm\) 6.03 & 19.55 \(\pm\) 1.45 & 25.25 \(\pm\) 2.51 & 15.62 \(\pm\) 3.30 & 4.13 \(\pm\) 1.52 & 4.45 \(\pm\) 0.89 & 15.71 \(\pm\) 0.69 & 17.59 \(\pm\) 1.73 & 10.91 \(\pm\) 5.08 & 10.94 \(\pm\) 0.29 \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 21.60 & 3.17 & 1027 & 1037 & 9.83 \(\pm\) 4.53 &  and & ed & ed & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 20.39 & 1395 & 1048 & nd & ed & ed & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 22.378 & 3.24 & 1066 & 1000 & nd & ed & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 24.99 & 3.22 & 1062 & nd & ed & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 24.87 & 3.33 & 1076 & 1001 & 1.88 \(\pm\) 0.38 & 7.62 \(\pm\) 5.74 & 1.00 \(\pm\) 0.33 & 2.11 \(\pm\) 0.12 & 1.80 \(\pm\) 0.29 & 1.80 \(\pm\) 0.68 & 2.07 \(\pm\) 0.28 & 2.31 \(\pm\) 0.68 \\ \multicolumn{13}{c}{**S**-Mycone**} & 24.87 & 3.33 & 1076 & 101 & 1.88 \(\pm\) 0.38 & 7.62 \(\pm\) 5.74 & 1.00 \(\pm\) 0.33 & 2.11 \(\pm\) 0.12 & 1.80 \(\pm\) 0.29 & 1.80 \(\pm\) 0.68 & 2.07 \(\pm\) 0.28 & 2.31 \(\pm\) 0.68 \\ \multicolumn{13}{c}{**S**-Mycone**} & 25.09 & 3.06 & 1093 & 1106 & nd & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 25.37 & 3.33 & 1086 & 1107 & 2.83 \(\pm\) 0.38 & 1.86 \(\pm\) 0.51 & 0.33 \(\pm\) 0.27 & 2.73 \(\pm\) 0.30 & 3.04 \(\pm\) 0.36 & 12.42 \(\pm\) 0.23 & 2.99 \(\pm\) 6.07 & 1.91 \(\pm\) 3.78 & 0.39 \(\pm\) 0.32 \\ \multicolumn{13}{c}{**S**-Mycone**} & 25.42 & 3.44 & 1077 & 112 & 0.01 & 0.04 \(\pm\) 0.77 & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 25.58 & 3.22 & 1170 & 1135 & nd & ed & ed & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 25.37 & 3.32 & 1190 & 1191 & nd & ed & ed & ed & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 25.36 & 3.56 & 1182 & 1209 & nd & ed & ed & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 34.62 & 3.43 & 1281 & 1209 & 2.28 \(\pm\) 0.64 & 1.26 \(\pm\) 0.20 & 2.50 \(\pm\) 1.13 & 2.77 \(\pm\) 0.51 & 2.46 \(\pm\) 0.58 & 1.97 \(\pm\) 0.11 & 1.85 \(\pm\) 0.44 & 2.90 \(\pm\) 1.13 & 3.40 \(\pm\) 0.47 \\ \multicolumn{13}{c}{**S**-Mycone**} & 33.86 & 1.23 & 8.07 \(\pm\) 2.26 & 5.61 \(\pm\) 0.19 & 2.80 \(\pm\) 1.13 & 2.80 \(\pm\) 0.34 & 2.20 \(\pm\) 3.36 & 2.30 \(\pm\) 0.84 & 5.79 \(\pm\) 3.75 & 2.22 \(\pm\) 0.49 & 48.23 \(\pm\) 5.58 \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 33.62 & 3.05 & 1348 & 1343 & nd & 1.13 \(\pm\) 0.18 & nd & 1.37 \(\pm\) 0.16 & nd & 0.72 \(\pm\) 0.11 & 1.87 \(\pm\) 0.44 & \(\pm\) 0.44 & 1.99 \(\pm\) 0.22 & 1.38 \(\pm\) 0.66 \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 34.66 & 3.55 & 1218 & 1209 & nd & ed & ed & ed & ed & ed & ed & ed & ed & ed \\ \hline \multicolumn{13}{c}{**S**-Mycone**} & 34.62 & 3.43 & 1281 & 1209 & 2.28 \(\pm\) 0.64 & 1.26 \(\pm\) 0.20 & 2.50 \(\pm\) 1.13 & 2.77 \(\pm\) 0.51 & 2.46 \(\pm\) 0.58 & 1.97 \(\pm\) 0.11 & 1.88 \(\pm\) 0.47 & 2.90 \(\pm\) 1.13 & 3.40 \(\pm\) 0.47 \\  
+++ ==ERROR: No output for this page==
\begin{table}
\begin{tabular}{l c c c c c c c c c c c c c} \hline \hline \multirow{2}{*}{**Compounds**} & \multirow{2}{*}{**1D**, **(initial)** \({}^{\circ}\)**} & \multirow{2}{*}{**2D**, **(initial)** \({}^{\circ}\)**} & \multirow{2}{*}{**LBL**\({}_{max}\)**\({}^{\circ}\)**} & \multirow{2}{*}{**LBL**\({}_{max}\)**\({}^{\circ}\)**} & \multirow{2}{*}{**LBL**\({}_{max}\)**\({}^{\circ}\)**} & \multicolumn{5}{c}{  
For the monoterpene class, attending to the relative area, it is observed that Cast was the variety that presented a higher total relative area, 69.34 \(\pm\) 4.32%, while Trinc presented the lowest total relative area, 20.27 \(\pm\) 3.48%.